Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology

J. Tímár, J. Fillinger

Source: Eur Respir Mon; 2010: 48: 272–296

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Tímár, J. Fillinger. Pathology of lung cancer: histology, cytology, immunohistochemistry and molecular pathology. Eur Respir Mon; 2010: 48: 272–296

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pathology and immunohistochemistry of lung cancer
Source: Eur Respir Mon; 2009: 44: 15–35
Year: 2009

Lung cancer: immunopathology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48
Year: 2001

Epidemiology, clinical, imaging and histology aspects of lung cancer in IPF
Source: Research Seminar 2015
Year: 2015


The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013


Accuracy of cell typing in nonsmall cell lung cancer by EBUS/EUS–FNA cytological samples
Source: Eur Respir J 2011; 38: 911-917
Year: 2011



Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015


Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma
Source: Eur Respir J 2013; 41: 943-951
Year: 2013



Molecular abnormalities and histopathology in lung cancer
Source: ERS Research Seminar
Year: 2015

Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens
Source: Eur Respir Rev, 26 (144) 170007; 10.1183/16000617.0007-2017
Year: 2017



Cytological diagnostics of lung cancer: our experience
Source: Eur Respir J 2005; 26: Suppl. 49, 306s
Year: 2005

Cytological specimens' relative contribution in establishing histological diagnosis of lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


Interobserver agreement in determining non-small cell lung cancer subtype in specimens acquired by EBUS-TBNA},
Source: Eur Respir J 2012; 40: 699-705
Year: 2012



Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016


Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006



Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Accuracy of PD-L1 tumour staining of cytological and histological samples of lung adenocarcinoma
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




Lung cancer: morphology
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=34
Year: 2001

mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013


An audit of prognostic significance of histological subtype in surgically resected adenocarcinomas
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016